NCT01074502View on ClinicalTrials.gov

Apremilast in the Treatment of Moderate to Severe Acne

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

October 31, 2010

Conditions
Acne
Interventions
DRUG

apremilast

apremilast 20 mgs orally twice a day for 12 weeks

Trial Locations (1)

27516

University Of North Carolina, Chapel Hill

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER